Monterey Innovation Acquisition Corp.
Status: Liquidated
U=S+W
W=S@11.50
| IPO Proceeds, $M | $115.00M |
|---|---|
| IPO Date | Oct 1, 2021 |
| CEO | Murat Omur |
| Left Lead | Chardan |
| IPO Cash in Trust | 101.0% |
| SPAC Tenor | 12 + 9 + 9 |
| IPO Sector |
Healthcare
Biotech |
| IPO Geography | Global |
| Target Company | N/A |
| Deal Announced | N/A |
| Deal Size, $M | TBD |
| Deal Sector | TBD |
| Deal Geography | TBD |
| SEC Filings | www.sec.gov |
| Approval Vote | TBD |
| Amendment Vote | Jul 3, 2023 |
| Closing Date | Nov 21, 2023 |
MTRY
MTRYU
MTRYW
| Price | |
|---|---|
| Volume, 3-month avg. | N/A |
Sign up for Free Trial
No credit card required
Sign in for more on Monterey Innovation Acquisition Corp.:
- Structure and cap table
- 9 directors & officers
- 15 filings and events
- 2 underwriters
Structure
Sign in to view structure, cap table, and calendar of events.
Team
| Name | Age | Title |
|---|---|---|
| Murat Omur | 45 | CEO |
| Sean McGann | 37 | CFO |
| Jonas Grossman | 47 | Executive Chairman and Director |
| Sandip I. Patel | 54 | Director |
| Frances K. Heller | 54 | Director |
| James R. Neal | 65 | Director |
| Chris Coleman | 52 | Director |
| Jory Des Jardins | 50 | Director |
| Roderick Hardamon | 46 | Director |
Sign in to view team biographies and more sponsor and affiliate data.
Advisors
Underwriters
| Chardan | BR | 9,950,000 | units |
| B. Riley FBR | 50,000 | ||
| 10,000,000 | units | ||
| Up-Front UW fee | 2.00 | % | |
| BCMA | 3.50 | % |
Sign in to view more advisor data.